SUVENNSESuven Life Sciences Limited· PharmaceuticalsLowNeutral
Announced Thu, 24 Jul · 15:57 IST

Suven Life Sciences Limited has informed the Exchange regarding Allotment of 214000 Shares.

Capital Market Events View source PDF

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Suven Life Sciences has allotted 2,14,000 equity shares to eligible employees who exercised their vested stock options under the SLSL ESOP 2020 scheme. The shares were issued at Rs. 55 each (face value Rs. 1 + premium Rs. 54), bringing in approximately Rs. 1.18 crore to the company. This increases the total paid-up equity share capital from 22,72,60,207 shares to 22,74,74,207 shares. The allotment was approved by the Nomination & Remuneration Committee on July 24, 2025, and the new shares rank equally with existing shares.

Likely market impact

This is a routine ESOP allotment with very minimal dilution of less than 0.1% to existing shareholders. The company receives around Rs. 1.18 crore in fresh capital, and the impact on share price or shareholder value is negligible.